Related Experiment Video

Updated: Jul 14, 2026

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
05:58

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

Published on: April 18, 2025

Reducing cardiovascular risk in diabetes

Michel Marre1

  • 1Groupe Hospitalier Bichat - Claude Bernard, Assistance Publique Hôpitaux de Paris, Paris, France.

Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|December 6, 2007
PubMed

Insights

High blood glucose levels are linked to cardiovascular disease, causing complications even before diabetes is diagnosed. While glucose control benefits heart health, evidence for reducing cardiovascular risk in diabetics is still developing.

Area of Science:

  • Endocrinology
  • Cardiology
  • Metabolic Diseases

Background:

  • Elevated blood glucose is strongly associated with cardiovascular disease (CVD).
  • Hyperglycemia initiates a cascade leading to microvascular and macrovascular complications.
  • Macrovascular issues can manifest at glucose levels below the diabetes threshold.

Purpose of the Study:

  • To explore the link between elevated glucose and cardiovascular complications.
  • To discuss the impact of glucose control on cardiovascular health in diabetes.
  • To highlight emerging understanding of CVD pathophysiology in diabetic patients.

Main Methods:

  • Literature review and synthesis of existing studies.
  • Analysis of the relationship between glucose levels and vascular complications.
  • Examination of the effects of glucose-lowering interventions on cardiovascular risk.

Main Results:

  • Hyperglycemia contributes to both microvascular and macrovascular complications.
  • Cardiovascular benefits of tight glucose control are observed, but evidence for risk reduction in diabetes is limited.
  • Treating hyperglycemia may mitigate lipid abnormalities, vascular issues, and hypertension.

Conclusions:

  • Understanding CVD pathophysiology in diabetes is crucial for early intervention.
  • Further research is needed to establish glucose-lowering efficacy for cardiovascular risk reduction in Type 1 and Type 2 diabetes.
  • Managing hyperglycemia offers potential benefits for cardiovascular health in diabetic populations.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...